Management and
advisors

We believe that building an engaged team starts with having a value-based company culture and a strong leadership team.

Scandinavian CRO

Meet the Management team

CEO and Founder

Ulrika Hammarström Lüllmaa

Ulrika holds a Master of Science in Molecular Biology as well as a postgraduate qualification in Clinical Drug Development from Uppsala University. Ulrika has worked in the CRO business since 2001 and has experience in a variety of roles including CRA manager, Clinical Project Leader and Country Manager. Scandinavian CRO is 100% privately owned by Ulrika.

Interim Financial Director

Eleonor Sallfeldt

Eleonor holds a Master of Science in Business and Economics from Örebro University. She has 18 years of experience working in finance, where she has worked as Commercial Finance Manager, Business Controller, Project Manager and Financial Consultant at several companies. She has also worked as Chief Financial Officer (CFO) at Warner Bros. International Television Production Sverige AB. Currently, Eleonor is Interim Financial Director at Scandinavian CRO.

Clinical Operations Manager

Ulrika Heldestad

Ulrika has more than 15 years of experience working with clinical studies in various positions in a broad range of therapeutic areas. With a background as a Research Nurse, Ulrika has worked as Project Manager, and Clinical Event Adjudication (CEA) Group Manager at the Uppsala Clinical Research Center (UCR).

Senior Advisor and Business Development Manager

Erik Olaisson

Erik has more than 30 years of experience working in the pharmaceutical and medtech industries including large pharma companies, small venture-funded companies, and virtual organizations. Erik brings to SCRO his extensive strategic and operational experience in product and clinical development within the pharmaceutical and medical device businesses. Erik’s most recent position was at Uppsala BIO (STUNS foundation) working in Business Development.

Financial Director

Britta Lindman

Britta holds a Master of Science in Business and Economics from the University of Gävle. After working 12 years as an Authorized Public Accountant at PwC and BDO, Britta worked in small- and medium-sized life science and growth companies in different roles including Group Audit Leader, Project Leader and Director.

Senior Advisor

Bengt Gustavsson

Bengt holds a Master of Science in Pharmacy, a PhD in the Medical Sciences from Uppsala University, as well as a Diploma in Pharmaceutical Medicine from the Swiss Association of Pharmaceutical Professionals and EUCOR universities. With more than 25 years of experience in the pharma industry, Bengt has held positions such as Nordic Medical Director at Novartis and Celgene and Nordic Clinical Research Director at Sanofi-Aventis. Bengt is currently Head of Global Medical Affairs at Oncopeptides AB, Board Director at Nanexa AB, and Owner/CEO of Sangus Jazz AB. Bengt has been involved in the launch of more than 10 different approved drugs and has worked in all phases of clinical studies.

Scandinavian CRO

Meet the Board of Directors

Chairman of the Board

Ulf Boberg

Ulf holds an MBA in Business Development and Economics, a Master’s degree in Pharmacy, and a PhD in Physiology from Uppsala University. With over 30 years of experience in pharma and medtech, Ulf has been active in roles such as CEO, Business Developer, Chairman of the Board and Senior Advisor in several pharmaceutical and biotechnology companies such as AstraZeneca, Global Genomics, Affibody, Creative Antibiotics, Miris Holding, Trial Form Support, and iNovacia (currently Kancera).

Board Member

Mattias Bergqvist

Mattias has a Bachelor of Science in Business and Marketing and has studied at the University of Dalecarlia, University of Borås, and Stockholm University. Mattias has more than 23 years of experience in the pharma and biotech industry. His previous experience includes roles as Nordic Marketing Director of Oncology at AstraZeneca and Global Brand Manager at AstraZeneca UK for different oncology drugs. Since 2012, Mattias has worked as Clinical Development Director at Biovica International AB as well as being active as a strategic consultant within pharma, medtech and biotech. Mattias has also been active in several clinical study collaborations including as a co-investigator in a Southwest Oncology Group trial (SWOG-trial).

CEO and Founder

Ulrika Hammarström Lüllmaa

Ulrika holds a Master of Science in Molecular Biology as well as a postgraduate qualification in Clinical Drug Development from Uppsala University. Ulrika has worked in the CRO business since 2001 and has experience in a variety of roles including CRA manager, Clinical Project Leader and Country Manager. Scandinavian CRO is 100% privately owned by Ulrika.